User:Lisa1235858/Choose an Article

Article Selection
Please list articles that you're considering for your Wikipedia assignment below. Begin to critique these articles and find relevant sources.

Option 1
(S)-2-hydroxy-fatty-acid dehydrogenase This is a stub article that only has the one source from the Wikipedia article, but I found another journal on Google Scholar specifically about this enzyme. However, those are the only two that show up as sources for this on Google Scholar.
 * Article title
 * Article Evaluation
 * Sources

Schomburg, Dietmar; Stephan, Dörte (1995), Schomburg, Dietmar; Stephan, Dörte (eds.), "(R)-2-Hydroxy-fatty-acid dehydrogenase", Enzyme Handbook 9: Class 1.1: Oxidoreductases, Berlin, Heidelberg: Springer, pp. 485–487, doi:10.1007/978-3-642-85200-8_94, ISBN 978-3-642-85200-8, retrieved 2021-10-14

Option 2
Receptor modulator This is a stub article that only has two sources from Wikipedia, but there are more sources on Google Scholar.
 * Article title
 * Article Evaluation

Bethesda, Cystic Fibrosis Foundation 4550 Montgomery Ave Suite 1100 N.; Md 20814301-951-4422 800-344-4823. "CFTR Modulator Therapies". www.cff.org. Retrieved 2021-10-14.
 * Sources

van Westen GJ, Gaulton A, Overington JP (April 2014). "Chemical, target, and bioactive properties of allosteric modulation". PLOS Computational Biology. 10 (4): e1003559. Bibcode:2014PLSCB..10E3559V. doi:10.1371/journal.pcbi.1003559. PMC 3974644. PMID 24699297.

Option 3
Versutoxin This article currently doesn't exist, but it would be about a neurotoxin found in spider venom. While looking at the stub article for Channel modulator, I found this in the Ion channel modulators section. Although there currently isn't an article for it, I found several sources about this topic and think it would be an interesting topic to start a Wikipedia article on. Lüddecke, Tim; Herzig, Volker; Reumont, Björn M. von; Vilcinskas, Andreas. "The biology and evolution of spider venoms". Biological Reviews. n/a (n/a). doi:10.1111/brv.12793. ISSN 1469-185X.
 * Article title
 * Article Evaluation
 * Sources

Fletcher, Jamie I; Chapman, Bogdan E; Mackay, Joel P; Howden, Merlin EH; King, Glenn F (1997-11). "The structure of versutoxin (δ-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel". Structure. 5 (11): 1525–1535. doi:10.1016/s0969-2126(97)00301-8. ISSN 0969-2126.

M R Brown, D D Sheumack, M I Tyler, M E H Howden; Amino acid sequence of versutoxin, a lethal neurotoxin from the venom of the funnel-web spider Atrax versutus. Biochem J 1 March 1988; 250 (2): 401–405. doi: https://doi.org/10.1042/bj2500401.

Nicholson, G.M., Willow, M., Howden, M.E.H. et al. Modification of sodium channel gating and kinetics by versutoxin from the Australian funnel-web spiderHadronyche versuta. Pflügers Arch. 428, 400–409 (1994). https://doi.org/10.1007/BF00724524.

Blumenthal, K.M., Seibert, A.L. Voltage-gated sodium channel toxins. Cell Biochem Biophys 38, 215–237 (2003). https://doi.org/10.1385/CBB:38:2:215.

Option 4
Racemorphan There's only one Wikipedia source for it, but I found more Google Scholar articles about the topic. "Conversion Factors for Controlled Substances". www.deadiversion.usdoj.gov. Retrieved 2021-10-14.
 * Article title
 * Article Evaluation
 * Sources

Seighal Delshad, Nazanin; Soleimanpour, Bahareh; Salehi, Peyman (2021), Moosavi-Movahedi, Ali Akbar (ed.), "Nature's Generosity in Protecting Human Health", Rationality and Scientific Lifestyle for Health, University of Tehran Science and Humanities Series, Cham: Springer International Publishing, pp. 31–59, doi:10.1007/978-3-030-74326-0_3, ISBN 978-3-030-74326-0, retrieved 2021-10-14.

Option 5
Ritanserin There are enough Wikipedia sources for this topic. Dr. Ian Morton; I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 249–. ISBN 978-0-7514-0499-9.
 * Article title
 * Article Evaluation
 * Sources

Akhondzadeh S, Malek-Hosseini M, Ghoreishi A, Raznahan M, Rezazadeh SA (September 2008). "Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: A double-blind randomized placebo-controlled study". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32 (8): 1879–83. doi:10.1016/j.pnpbp.2008.08.020. PMID 18801405. S2CID 12270281.

Nappi, G; Sandrini, G; Granella, F; Ruiz, L; Cerutti, G; Facchinetti, F; Blandini, F; Manzoni, GC (June 1990). "A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline". Headache. 30 (7): 439–44. doi:10.1111/j.1526-4610.1990.hed3007439.x. hdl:11380/740716. PMID 2119355. S2CID 25781431.

Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM (1985). "Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist". Mol Pharmacol. 27 (6): 600–11. PMID 2860558.

Harmful Non-Indigenous Species in the United States. DIANE Publishing. 1 February 1993. pp. 361–. ISBN 978-0-7881-0441-1.

Bentham Science Publishers (May 1994). Current Medicinal Chemistry. Bentham Science Publishers. pp. 52–.